Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review (Q35627775)

9 August 2017

1 reference

title

Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review (English)

1 reference

9 August 2017

Sean B Ainsworth

1

1 reference

9 August 2017

David W A Milligan

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2002

1 reference

Treatments in Respiratory Medicine

9 August 2017

published in

1 reference

9 August 2017

volume

1

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

417-433

1 reference

Artificial surfactant therapy in hyaline-membrane disease

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Birth weight and age-specific analysis of the 1990 US infant mortality drop. Was it surfactant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Doctors revise declaration of Helsinki

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

The composition and function of reptilian pulmonary surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

The role of lipids in pulmonary surfactant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

The pulmonary surfactant system: biochemical and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Functional roles and structural analysis of lung collectins SP-A and SP-D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Rhabdomyolysis as a complication of 5-azacytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Surfactant Protein A, Phosphatidylcholine, and Surfactant Inhibitors in Epithelial Lining Fluid: Correlation with Surface Activity, Severity of Respiratory Distress Syndrome, and Outcome in Small Premature Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Isolation and characterization of the human pulmonary surfactant apoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Characterization of a second human pulmonary surfactant-associated protein SP-A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Hydrophobic proteins of lamellated osmiophilic bodies isolated from pig lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Structure and properties of surfactant protein B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Surfactant protein SP-B induces ordering at the surface of model membrane bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Interaction of lipid vesicles with monomolecular layers containing lung surfactant proteins SP-B or SP-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Molecular structures and interactions of pulmonary surfactant components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: II. Monolayers of pulmonary surfactant protein SP-C and phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Hydrophobic lung surfactant proteins B and C remain associated with surface film during dynamic cyclic area changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Altered stability of pulmonary surfactant in SP-C-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

A mutation in the surfactant protein C gene associated with familial interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

The surface properties of chemically synthesized peptides analogous to human pulmonary surfactant protein SP-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Dose‐response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

A synthetic segment of surfactant protein A: structure, in vitro surface activity, and in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Physical and physiological properties of dry lung surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Effects of artificial surfactant on lung function and blood gases in idiopathic respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Component-specific surface and physiological activity in bovine-derived lung surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. Northern Neonatal Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Cerebral blood flow velocity changes after rapid administration of surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Cerebral blood flow and plasma hypoxanthine in relation to surfactant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Synthetic mimics of surfactant proteins B and C: in vitro surface activity and effects on lung compliance in two animal models of surfactant deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Comparative randomized study: administration of natural and synthetic surfactant to premature newborns with respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Systematic review of prophylactic vs rescue surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

"Click test": rapid diagnosis of the respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Circulatory changes after surfactant bolus instillation in lung-lavaged adult rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Haemodynamic effects of altering arterial oxygen saturation in preterm infants with respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Rapid tracheal infusion of surfactant versus bolus instillation in rabbits: effects on oxygenation, blood pressure and surfactant distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Nebulisation of surfactants in an animal model of neonatal respiratory distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Distribution of surfactant, lung compliance, and aeration of preterm rabbit lungs after surfactant therapy and conventional and high-frequency oscillatory ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

[Early continuous positive pressure in the labor room]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Declining severity adjusted mortality: evidence of improving neonatal intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Follow up of premature babies treated with artificial surfactant (ALEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Cost implications of different approaches to the prevention of respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Estimated costs of different treatments of the respiratory distress syndrome in a large cohort of preterm infants of less than 30 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Prospective Randomized Multicenter Comparison of High-Frequency Oscillatory Ventilation and Conventional Ventilation in Preterm Infants of Less Than 30 Weeks With Respiratory Distress Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Acute Effects on Systemic and Pulmonary Hemodynamics of Intratracheal Instillation of Porcine Surfactant or Saline in Surfactant-Depleted Newborn Piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257169

21 January 2018

Identifiers

DOI

10.1007/BF03257169

1 reference

9 August 2017

1 reference